A StuDy eVAluatiNg the EffiCacy and Safety of RalinEpag To Improve Treatment OUTCOMES in PAH Patients (ADVANCE-outcomes) (NCT03626688)
ADVANCE-outcomes
This trial is No longer recruiting
Registration number NCT03626688
Program & service
This trial is being run with the Heart & Lung service, and as part of the Respiratory program.
Trial phase
Phase 3
Trial participation type
This trial has been designed for the Clinical Research of a Drug.
Principal investigator
Professor Trevor Williams
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTR